Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 103,317 | 169,355 | 117,477 | 616,931 | 121,608 |
| Marketable Securities | 517,544 | 512,088 | 494,666 | 325,443 | 503,183 |
| Receivables | 201,056 | 200,306 | 145,980 | 125,036 | 114,062 |
| Inventories | 81,355 | 63,534 | 56,520 | 51,628 | 38,169 |
| Other current assets | 0 | 0 | 0 | 50,000 | 0 |
| TOTAL | $926,997 | $963,771 | $832,453 | $1,183,760 | $788,135 |
| Non-Current Assets | |||||
| PPE Net | 199,550 | 70,760 | 69,529 | 67,727 | 65,709 |
| Other Non-Current Assets | 41,594 | 40,331 | 40,788 | 36,696 | 22,383 |
| TOTAL | $241,144 | $111,091 | $110,317 | $104,423 | $88,092 |
| Total Assets | $1,168,141 | $1,074,862 | $942,770 | $1,288,183 | $876,227 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 77 | 89 | 149 | 194 | 263 |
| Accounts payable and accrued liabilities | 24,685 | 23,638 | 24,096 | 24,406 | 17,254 |
| Accrued Expenses | 43,012 | 43,839 | 48,987 | 28,574 | 29,012 |
| TOTAL | $133,402 | $136,589 | $130,012 | $104,892 | $85,476 |
| Non-Current Liabilities | |||||
| Long Term Debt | 390 | 328 | 268 | 273 | 293 |
| Deferred Revenues | 7,167 | 8,191 | 4,936 | 7,692 | 7,155 |
| Other Non-Current Liabilities | 595,000 | 595,000 | 595,000 | 595,000 | 250,000 |
| TOTAL | $616,407 | $611,267 | $611,576 | $611,950 | $267,922 |
| Total Liabilities | $749,809 | $747,856 | $741,588 | $716,842 | $353,398 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,620,038 | 1,610,843 | 1,600,305 | 1,588,027 | 1,573,459 |
| Common Shares | 202 | 201 | 200 | 198 | 197 |
| Retained earnings | -646,226 | -719,322 | -819,694 | -381,640 | -417,119 |
| Other shareholders' equity | 2,719 | 4,656 | 2,666 | 2,475 | 2,469 |
| TOTAL | $418,332 | $327,006 | $201,182 | $571,341 | $522,829 |
| Total Liabilities And Equity | $1,168,141 | $1,074,862 | $942,770 | $1,288,183 | $876,227 |